Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04705363 · ClinicalTrials.gov registry record · NA
A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 751
- Enrollment target
NCT04705363: Completed NA study, sponsored by University of Florida.
NCT04705363 is a NA study that has completed, run by University of Florida. The registered enrollment target is 751 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04705363, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 751 participants
- Enrollment target
Study Summary
This pilot study will explore the preliminary efficacy of a colorectal cancer (CRC) screening intervention delivered by Virtual Human Agents (VHAs). Seven hundred fifty participants aged 45 to 75 will be recruited through Qualtrics panels. The study examines how different levels of dialectal linguistic features willingness to be screened for colorectal cancer. Participants will be randomly assigned to interact with one of four VHA conditions: a VHA using non-dialectal linguistic features, a VHA with a low level of dialectal linguistic features integrated, a VHA with a high level of dialectal linguistic features integrated, or a text-only control condition. Following the interaction, participants will complete survey measures to assess perceived willingness to be screened.
Primary Outcome
Measure: Intention to talk to a doctor about colorectal cancer screening. Construct: Behavioral intention to communicate Item: The virtual appointment made me want to discuss colon cancer screening options with my doctor. Participants will respond using three 5-point Likert scales that will be summed. The total score ranges from 3 to 15, with higher scores indicating a greater intention to discuss colorectal cancer screening with a healthcare professional. Mean scores closer to 3 reflect lower
Interventions
- BEHAVIORAL Text-only
- BEHAVIORAL High Dialectal
- BEHAVIORAL Low Dialectal
- BEHAVIORAL Non-Dialectal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 751 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-12-18 |
| Phase | NA |
What the finished NCT04705363 record still lists
NCT04705363 is an interventional study that assigns participants to a tested intervention. The registered 751 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 4 interventions - of which Text-only is the first listed.
NCT04705363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04705363 about?
NCT04705363 is a clinical study titled "A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans". This pilot study will explore the preliminary efficacy of a colorectal cancer (CRC) screening intervention delivered by Virtual Human Agents (VHAs). Seven hundred fifty participants aged 45 to 75 will be recruited through Qualtrics panels. The study examines how different levels of dialectal linguis...
What is the current status of trial NCT04705363?
This trial is currently completed. It is a NA study. The enrollment target is 751 participants. The study started on 2021-06-29. Estimated completion is 2023-12-18.
What interventions are being tested in trial NCT04705363?
The interventions under investigation include: Text-only (BEHAVIORAL), High Dialectal (BEHAVIORAL), Low Dialectal (BEHAVIORAL), Non-Dialectal (BEHAVIORAL).
Who is sponsoring clinical trial NCT04705363?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04705363's enrollment target sits among peer trials
751 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06559306 · 752 participants · Phase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI